NLRP3 inflammasome inhibition by the novel bispecific antibody InflamAb attenuates atherosclerosis in apolipoprotein e–deficient mice

Author(s):
Delfos, L. (0000-0003-1018-191X); Depuydt, M.A.C. (0000-0002-7174-1952); Chemaly, M.; Coyle, S.; Schaftenaar, F.H. (0000-0001-5742-489x); Santbrink, P.J. van; Lindenbergh, P.P. (0009-0003-4816-2455); Bernabé Kleijn, M.N.A. (0000-0001-6027-6154); Costello, C.; Power, C.A.; Coll, R.; Peace, A.; Gregory-Ksander, M.; Foks, A.C. (0000-0002-9747-3458); Kuiper, J. (0000-0001-5834-690X); McGilligan, V.; Bot, I. (0000-0002-1242-1959)
Published
2025
Publication type
Article / Letter to editor
AtherosclerosisBispecificAntibodyInterleukin-1 receptor type 1Interleukin-1bNLRP3 inflammasome
Date issued
2025-03-05
Language
English
Is part of
JACC: Basic to Translational Science (2025), Vol. 10, no. 6, p. 826-840
hdl
1887/4212171
doi
10.1016/j.jacbts.2024.12.012